BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8455096)

  • 1. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
    Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
    Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of chronic berylliosis].
    Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
    Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
    Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
    Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beryllium--underestimated occupational health hazard in Poland].
    Dudek W; Walusiak J; Wittczak T
    Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to beryllium: uses, regulatory history, and disease.
    Kolanz ME
    Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening blood test identifies subclinical beryllium disease.
    Kreiss K; Newman LS; Mroz MM; Campbell PA
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of a program to prevent beryllium disease.
    Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
    Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BeLPT: algorithms and implications.
    Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
    Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
    Deubner DC; Goodman M; Iannuzzi J
    Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of berylliosis/sarcoidosis in a dental technician].
    Müller-Quernheim J; Zissel G; Schopf R; Vollmer E; Schlaak M
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1462-6. PubMed ID: 8983896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.